Sulthiame
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB08329 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | cauda equina syndrome | KG + DL |
| 2 | obsolete neurogenic bladder (disease) | KG + DL |
| 3 | irritable bowel syndrome | KG + DL |
| 4 | neurocirculatory asthenia | KG + DL |
| 5 | anaphylaxis | KG + DL |
| 6 | food-dependent exercise-induced anaphylaxis | KG + DL |
| 7 | familial mitral valve prolapse | KG + DL |
| 8 | mitral valve prolapse (disease) | KG + DL |
| 9 | MVP1 | KG + DL |
| 10 | autonomic nervous system disease | KG + DL |
| 11 | bronchitis | KG + DL |
| 12 | panuveitis (disease) | KG + DL |
| 13 | uveitis | KG + DL |
| 14 | dysautonomia | KG + DL |
| 15 | postural orthostatic tachycardia syndrome | KG + DL |
| 16 | idiopathic bronchiectasis | KG + DL |
| 17 | iris disease | KG + DL |
| 18 | insomnia (disease) | KG + DL |
| 19 | dermatitis | KG + DL |
| 20 | focal chorioretinitis | KG + DL |
| 21 | disseminated chorioretinitis | KG + DL |
| 22 | pseudoallergy | KG + DL |
| 23 | restless legs syndrome | KG + DL |
| 24 | abnormal pupillary function (disease) | KG + DL |
| 25 | idiopathic panuveitis | KG + DL |
| 26 | pars planitis | KG + DL |
| 27 | idiopathic uveal effusion syndrome | KG + DL |
| 28 | obesity disorder | KG + DL |
| 29 | isolated iridoschisis | KG + DL |
| 30 | multiple system atrophy | KG + DL |
| 31 | ciliary body disease | KG + DL |
| 32 | benign neoplasm of iris | KG + DL |
| 33 | iris cancer | KG + DL |
| 34 | neuralgia | KG + DL |
| 35 | ciliary body neoplasm | KG + DL |
| 36 | pulverulent cataract | KG + DL |
| 37 | acrodermatitis chronica atrophicans | KG + DL |
| 38 | variably protease-sensitive prionopathy | KG + DL |
| 39 | hypervitaminosis | KG + DL |
| 40 | secondary interstitial lung disease specific to childhood associated with a connective tissue disease | KG + DL |
| 41 | hydroa vacciniforme, familial | KG + DL |
| 42 | neonatal dermatomyositis | KG + DL |
| 43 | peripheral motor neuropathy-dysautonomia syndrome | KG + DL |
| 44 | amyopathic dermatomyositis | KG + DL |
| 45 | proximal 16p11.2 microdeletion syndrome | KG + DL |
| 46 | acne keloid | KG + DL |
| 47 | anxiety | KG + DL |
| 48 | sinoatrial node disease | KG + DL |
| 49 | corneal neovascularization | KG + DL |
| 50 | cataract - microcornea syndrome | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.